文献

J-GLOBAL ID：201902217509453991   整理番号：19S1685807

Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells

著者 (9件)： Zhu, Pengxiang (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Hata, Ryuji (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Cao, Fang (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Sakanaka, Masahiro (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Ogasawara, Masahito (Department of Pharmacology, Ehime University Graduate School of Medicine) ,  Maeyama, Kazutaka (Department of Pharmacology, Ehime University Graduate School of Medicine) ,  Kameda, Kenji (Integrated Center for Science, Ehime University Graduate School of Medicine) ,  Yamauchi, Kohei (Third Department of Internal Medicine, Iwate Medical University School of Medicine) ,  Schinkel, Alfred H. (Division of Molecular Biology, Netherland Cancer Institute)
資料名： Journal of Cerebral Blood Flow and Metabolism
巻： 32  号： 10  ページ： 1897-1908  発行年： 2012年 
JST資料番号： SCOPUS  ISSN： 0271-678X  CODEN： JCBMD 
発行国： アメリカ (USA)  言語： 英語 (EN)

タイトルに関連する用語 (1件)： OCT3